Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke

BACKGROUND: Thrombolytic treatment (tissue-type plasminogen activator [tPA]) is only recommended for acute ischemic stroke patients with stroke onset time <4.5 hours. tPA is not recommended when stroke onset time is unknown. Diffusion-weighted MRI (DWI) and fluid attenuated inversion recovery (FL...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Ankur, Eggman, Ashley A., Kamel, Hooman, Gupta, Ajay, Schackman, Bruce R., Sanelli, Pina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740488/
https://www.ncbi.nlm.nih.gov/pubmed/26840397
http://dx.doi.org/10.1371/journal.pone.0148106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740488/
https://www.ncbi.nlm.nih.gov/pubmed/26840397
http://dx.doi.org/10.1371/journal.pone.0148106

Ejemplares similares